Eravacycline

Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback
Xconomy
Wed, 02/14/18 - 11:43 am
FDA
Tetraphase Pharmaceuticals
clinical trials
Eravacycline
antibiotics
Tetraphase Pharmaceuticals Antibiotic Fails Against J&J Drug In Trial; Stock Plunges 79% After-Hours
Bidness, ETC
Wed, 09/9/15 - 08:07 am
Tetraphase Pharmaceuticals
JNJ
antibiotics
Eravacycline
superbugs
3 Biotech Stocks to Buy With Huge Catalysts Coming Soon
24/7 Wall St
Mon, 08/3/15 - 12:17 pm
Biomarin
drisapersen
Cempra
Solithromycin
antibiotics
Tetraphase Pharmaceuticals
Eravacycline
Tetraphase spikes on a Phase III success for lead antibiotic
Fierce Biotech
Wed, 12/17/14 - 09:41 pm
antibiotics
Tetraphase Pharmaceuticals
Eravacycline
Tetraphase Oral Antibiotic Data Look Good
TheStreet.com
Wed, 09/3/14 - 08:03 am
antibiotics
Tetraphase Pharmaceuticals
Eravacycline
Previewing Tetraphase Oral Antibiotic Study Results
TheStreet.com
Wed, 08/27/14 - 08:20 am
Tetraphase Pharmaceuticals
antibiotics
Eravacycline
urinary tract infection
Tetraphase Pharmaceuticals: A Small Cap With Big Potential
Seeking Alpha
Sat, 01/4/14 - 04:14 pm
Tetraphase Pharmaceuticals
AstraZeneca
Cubist Pharmaceuticals
antiobiotics
Eravacycline
JNJ
Merck
Pfizer
FDA Grants QIDP Designation to Eravacycline, Tetraphase’s Lead Antibiotic Product Candidate
Yahoo
Mon, 07/15/13 - 10:29 am
Eravacycline
Tetraphase Pharmaceuticals
antiobiotics
QIDP